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Summary. The aim of our work was to optimize and apply simple high-performance 
liquid chromatography method with ultraviolet detection (HPLC–UV) for simultaneous 
determination of reduced (GSH) and oxidized (GSSG) glutathione in biological matrix 
(specifically, the rat liver tissue was used herein), since the ratio between oxidized and 
reduced glutathione forms (GSSG–GSH) has been recognized as an important biological 
marker of oxidatively depleted GSH in oxidative stress (OS)-associated diseases and poi-
sonings. An isocratic chromatographic separation of GSH and GSSG (2.8 min and 6.3 
min, respectively) was performed with the mobile phase consisted of sodium perchlorate 
solution (pH adjusted to 2.8) at flow rate of 1 mL min−1, detection set at 215 nm, and col-
umn temperature of 40 °C. The method offers short run time, linearity in the range of 
0.01–200 µM concentration for both compounds (R2 = 1), low limits of detection and 
quantification (GSH: 0.18 µM and 0.56 µM, GSSG: 0.52 µM and 1.58 µM, respectively), 
precision, accuracy (bias < 2%), and high reproducibility.  
Through suitable sample handling, an overestimation of GSSG was prevented. 
High recovery (>99%) was achieved. The method was successfully applied for the analy-
sis of GSH and GSSG in liver homogenates of Wistar rats intraperitoneally exposed to 
cadmium (Cd) (1 mg kg−1 CdCl2/21 days). Regardless of other Cd-mediated hepatotoxi-
city mechanisms, herein, we have exclusively interpreted/emphasized oxidative GSH 
depletion. 
The presented method is acceptable for a routine analysis of GSH and GSSG in bio-
logical matrix, while the calculated ratio GSSG–GSH is considered as a valuable OS 
marker.  
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Within the elucidation of pathophysiological mechanisms, the interpreta-
tion of oxidative stress (OS) has attracted great attention during recent dec-
ades. Glutathione cycle is the essence of antioxidative response to OS exog-
enously/endogenously induced in living organisms. Considered to be a 
principal endogenous antioxidant [1], glutathione (GSH) reacts with metab-
olite intermediates forming mercapturic acid conjugates (second phase of 
metabolism) [2]. Additionally, a potential chelating property of GSH is tak-
en into consideration for the detoxification of toxic metals. Glutathione is a 
tripeptide that consists of glycine, glutamate, and cysteine, present in mi-
cromolar (µM) concentrations in body fluids and in millimolar (mM) con-
centrations in tissues [3]. Under physiological conditions, reduced form of 
glutathione (GSH) is prevalent (~90% of total glutathione). GSH depletion 
occurs in accordance with OS development, due to its oxidation into disul-
fide form (GSSG). This is not the case within reactions of conjugation 
and/or chelation (when GSSG production does not occur). Thus, an in-
creased ratio GSSG–GSH is considered as a sensitive and indicative bi-
omarker of OS-associated diseases/poisonings [1]. Therefore, simultaneous 
determination of both glutathione forms is of great importance for the relia-
ble interpretation of the GSH depletion. 
Numerous methods are available for measuring GSH and GSSG in bio-
logical samples. Most of those methods are spectrophotometric, allowing 
determination of total and reduced glutathione, while the amount of GSSG 
corresponds to their difference. Several equations proposed for the calcula-
tion of total glutathione often lead to false estimation of GSSG level [1]. Pre-
viously developed techniques including enzymatic [4], fluorometric [5], and 
colorimetric [6] assays provided inadequate detection limits and poor speci-
ficity. Electrochemical methods avoiding derivatization have also been pro-
posed previously [7], though loss of sensitivity of electrodes after a few 
hundred injections and the necessity of reconditioning are the major disad-
vantages of electrochemical methods. Furthermore, currently available 
high-performance liquid chromatography (HPLC) procedures for GSH 
and/or GSSG determination require a demanding sample preparation, in-
cluding pre- or post-column derivatization [8]. A resulting overproduction 
of GSSG (GSH oxidation), which often occurs during alkalization and deri-
vatization phase, is the major disadvantage of such sample preparation pro-
tocol [9, 10]. Although liquid chromatography–tandem mass spectrometry 
(LC–MS/MS) is the technique of choice for the simultaneous determination 
of GSH and GSSG (taking into consideration specificity and low limits of 
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detection and quantification), it is inaccessible to many laboratories [11–13]. 
Other methods, such as micellar electrokinetic capillary electrophoresis 
(MEKC) [14], nuclear magnetic resonance (NMR) [15], fluorescence [16], and 
chemiluminescence-based methods, have also been proposed [17]. The lack 
of total automatization and inability to determine protein-bound glutathi-
one are the major limitations of capillary electrophoresis; NMR is not com-
monly available in clinical laboratories; fluorescence requires previous deri-
vatization, while GSSG determination is not achievable by chemilumines-
cence methods. 
Herein, we presented an isocratic HPLC–UV method enabling direct 
and simultaneous measurement of both glutathione forms with minimal bi-
ological sample handling avoiding derivatization. The method’s applicabil-
ity was tested in liver homogenates of the Wistar rats subacutely and intra-
peritoneally (i.p.) exposed to cadmium (Cd) and in the intact group. Cad-
mium may interfere with glutathione cycle through competition with essen-
tial metals at active sites of the antioxidative metalloenzymes and binding 
with thiol (–SH) groups of proteins, including GSH. 
 
 
Materials and Methods 
 
Experimental Protocol (Animal Study) 
 
The experiment was conducted on male Wistar rats weighing in the range 
of 220–250 g randomly divided into the control group (intact group: n = 6) 
and the experimental group further subdivided into four groups (n = 6) ac-
cording to the time of i.p. exposure to 1 mg CdCl2 kg−1 day−1 for 1, 3, 10, and 
21 days (Cd1, Cd3, Cd10, and Cd21 groups, respectively). The animals were 
sacrificed by decapitation, and liver was immediately removed and pre-
pared for the analysis according to the proposed protocol. Experimental an-
imals were treated according to the Guidelines for Animal Study, No. 
12032014/9 (Ethics Committee of the Military Medical Academy, Belgrade, 
Serbia and Montenegro). The rats were housed and adapted for the experi-
ment under standardized housing conditions (ambient temperature of 23 ± 
2 °C, relative humidity of 55 ± 3%, and a light–dark cycle of 13/11 h) and 
had free access to standard laboratory pellet food and tap water. All exper-
iments were performed after a 7-day period of adaptation to laboratory 
conditions. 





Glutathione reduced form (98–100% purity) and glutathione oxidized form 
(99% purity) were obtained from Sigma-Aldrich Chemie (Steinheim, Ger-
many), as well as ortho-phosphoric acid (OPA), and metaphosphoric acid 
(MPA). Sodium perchlorate monohydrate (NaClO4 • H2O) was obtained 





Glutathione status (GSSG–GSH ratio) was determined in the liver homoge-
nates of Wistar rats after 1, 3, 10, and 21 days of the treatment. The present-
ed modified HPLC–UV method was used for simultaneous determination 




Stock solutions of GSH and GSSG (1 mM) were prepared in 100 mM sodium 
perchlorate solution (pH was adjusted to 2.8 with 0.1% OPA) and stored at 
4 °C. Working standard solutions were prepared daily via dilution in sodi-
um perchlorate solution. 
 
Sample collection and preparation 
 
Tissue sample preparation required homogenization in 1 mL ice-cold saline 
solution followed by addition of 1 mL ice-cold MPA (5% w/v) for depro-
teinization. Liver homogenates were immediately centrifuged at 4 °C and 
8000 rpm for 25 min. Resulting supernatant was used for chromatographic 
analysis or stored at −20 °C until analysis, while sediment was used for pro-
tein measurement. All tissue samples were kept on ice during the whole 
procedure. The results were expressed as nmol of GSH or of GSSG per mg 
of proteins. The Lowry method was used for protein determination [18]. 
The GSSG–GSH ratio was considered during interpretation of the results. 
 
 
Apparatus and chromatographic conditions 
 
HPLC analyses were performed on a Shimadzu Corporation HPLC system 
consisting of an LC-30AD Nexera Liquid Chromatograph Pump system, a 
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CTO-30A Nexera Column Oven, an SPD-M20A Prominence Diode Array 
Detector, a CBM-20A Prominence Communications Bus Module, an SIL-
30AC Nexera Autosampler, and a DGU-20A5 Prominence Degasser, all 
manufactured by Shimadzu USA Manufacturing INC (Canby, OR, USA). 
For instrument control, data acquisition and data analyses, LabSolutions 
Main-system administrator, and Nexera software by Shimadzu (2008–2010) 
were used.  
The chromatographic separation was accomplished on ZORBAX 
Eclipse AAA (4.6 × 150 mm, 3.5 µm) analytical column (Agilent Technolo-
gies) set at 40 °C and a flow rate of 1 mL min−1. The detector was set at 215 
nm. Isocratic separation was performed with the mobile phase consisting of 
100 mM sodium perchlorate solution (pH was adjusted to 2.8 with 0.1% 
OPA). Injection volumes were 50 µL. 
Identification and quantification of the GSH and GSSG peaks obtained 
from biological samples were ensured by comparisons with the correspond-
ing data obtained from standard solutions. 
 
 
Validation Study Protocol 
 
Calibration curve analysis 
 
The calibration curves were constructed by plotting peak areas against 
known GSH and GSSG concentrations (0.01–200 µM). In accordance with 
the common procedure, the low limits of detection and quantification 
(LLOD and LLOQ) were determined by the analysis of solutions with 
known concentrations of the analyte and by establishing the minimum level 
at which the analyte can be reliably detected (testing showed that 0.01 µM is 
reliably detected). Standard errors of the predicted y-values for each x in the 
regression (STEYX) were estimated statistically. LLOD and LLOQ were cal-
culated based on the standard deviation of the response and the slope of de-
fined calibration curve (3× STDEV of low concentration/slope of the calibra-
tion curve and 10× STDEV of low concentration/slope of the calibration 
curve, respectively).  
 
Stability study procedure 
 
The stability of GSH and GSSG in biological samples was tested referring to 
different time and temperature storage conditions, at three concentration 
levels in triplicate. Liver homogenates of Wistar rats were spiked with 25, 
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50, and 100 µM of GSH and GSSG in final concentration. The samples were 
subjected to short term temperature conditions for: (a) 1 h and 4 h at room 
temperature (the samples were stored on the HPLC autosampler); (b) 24 h 
at 4 °C, in the refrigerator; and (c) 24 h, at −20 °C. Stability of the samples 
was expressed as a percentage of decrease of GSH and GSSG peak areas re-
lated to different time (hours) and temperature (°C) storage conditions.  
In order to prevent possible loss of GSH and the GSSG overestimation 
during sample handling, acid deproteinization was performed shortly after 
sample collection. Upon prompt centrifugation, acid supernatants were 
immediately analyzed or stored at −20 °C until analysis. Such stored super-
natants gave good reproducibility for as long as 1 month, though immedi-
ately analyzed supernatants gave better chromatographic separation and 
peak sharpness. 
 
Recovery study procedure 
 
Recovery was evaluated at three concentration levels within calibration 
range. Taking into consideration the presence of the endogenous GSH and 
GSSG, liver homogenate of Wistar rat was divided in four portions; one 
portion was used as a biological matrix sample, and the other three were 
spiked with adequate portions of mixed GSH and GSSG stock solutions to 
obtain final concentrations of 1, 25, and 100 µM. Three different liver ho-
mogenates were fortified for recovery analyses. Upon applied experimental 
protocol, supernatants of spiked samples were injected for chromatographic 
analysis. For estimation of recovery, the peak areas of fortified samples 





Data were analyzed with one-way ANOVA and Tukey’s test for post-hoc 
multiple comparisons. PASW Statistics 18.0 software was used. Values are 
presented as mean ± standard deviations. Differences were considered sta-
tistically significant for p < 0.05. 
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Results and Discussion 
 
Development and Optimization of the Method 
 
The purpose of the study was to improve and modify previously reported 
HPLC methods for direct and simultaneous determination of GSH and 
GSSG levels in biological samples. 
 
 
Analytical column selection 
 
Multiple HPLC columns were tested in order to optimize chromatographic 
resolution. The highest peak resolution (>2), based on GSH and GSSG sepa-
ration, was accomplished with the reversed-phase ZORBAX Eclipse AAA 
(4.6 × 150 mm, 3.5 µm) analytical column. Chromatographic separation was 
consistent throughout all performed measurements. Also, high peak resolu-
tion (>1) was accomplished with ZORBAX C8 Eclipse X-DB (4.6 × 150 mm,  
5 µm) analytical column. 
The column temperature was also tested for optimization. Testing 
showed that chromatographic resolution was the highest at 25 °C, but en-
hancement of the temperature to 40 °C increased peak sharpness and short-
ened the time of analysis.  
The column needs to be daily washed with acetonitrile and then recon-
ditioned with the mobile phase prior analysis in order to achieve consistent 
separation of GSH and GSSG. 
 
 
Mobile phase optimization 
 
Modifications were made in molar concentration of the mobile phase con-
stituent. Adjustment of sodium perchlorate solution molarity to 100 mM al-
lowed more consistent chromatographic separation of GSH and GSSG 
peaks in tested samples compared to 50 mM sodium perchlorate solution, 
even though the areas under detected peaks remained comparable. Also, 
due to the higher molarity, eluted peaks of GSH and GSSG were more 
symmetrical with less occurrence of GSH peak splitting. Chromatographic 
separation changed markedly due to changes in pH value of the mobile 
phase, resulting in the highest chromatographic resolution and consistency 
of retention times for GSH and GSSG peaks at pH value adjusted to 2.8. 
Changes in pH value above 3 or close to 2 significantly reduced chromato-
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graphic resolution and separation, declined up to the point when it was not 
achievable. Addition of methanol and/or acetonitrile to the mobile phase 
severely impaired chromatographic resolution, e.g., 15% of methanol in 
mobile phase disrupted detection of GSH and GSSG. It was also concluded 
that mobile phase needs to be freshly prepared or stored overnight in the re-
frigerator at 4 °C. We also attempted to change the mobile phase constituent 
in order to use a chemical commonly used for other analyses in laboratories. 
The use of 100 mM potassium dihydrogen phosphate solution, with pH ad-
justed to 2.8, actually allowed detection of both GSH and GSSG. Though 
chromatographic separation was less satisfactory, the use of potassium di-
hydrogen phosphate solution shortened the time of analysis.  
 
 
Sample preparation improvement 
 
Sulfosalicylic (SSA) acid was tested as a protein-precipitating agent. It re-
sulted in a large initial interfering peak overlapping GSH peak and caused 
the GSSG peak to disappear entirely, which lead to a conclusion that both 
forms of glutathione were already precipitated by the SSA. Thus, sample 
preparation protocol included the use of MPA as a protein-precipitating 
agent. The resulting chromatograms show that no interfering peaks occur 
due to the use of MPA. Adjusted protocol included the use of saline solu-
tion for homogenization instead of sodium perchlorate solution and EDTA, 
possibly leading to achievement of significantly higher recovery of GSSG 
compared to previous report [19]. 
Improvement of the method refers to high reproducibility, consistent 
chromatographic separation, advanced symmetry, and resolution of GSH 
and GSSG peaks, allowing more precise and accurate integration, while ap-
plied sample preparation protocol supports high recovery of GSSG.  
 
 
Chromatograms of GSH and GSSG from standard solutions and from liver 
homogenates extracts 
 
Chromatogram of the mixed standard solution of GSH and GSSG is shown 
in Fig. 1a in Appendix B. At used chromatographic conditions, selectivity fac-
tor (α = k′b/ k′a) was higher than 3 which is within the ideal range of α (1 to 
5), confirming an excellent separation of GSH and GSSG on the selected 
column. Optimized chromatographic conditions resulted also in short run 
times and sharp and symmetrical peaks of GSH and GSSG.  
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To demonstrate applicability of our HPLC–UV method, we measured 
GSH and GSSG level in liver homogenates of Wistar rats in the control 
group and the experimental groups (Appendix B, Fig. 1b and c). Unidentified 







The selectivity was demonstrated by comparing retention times and spec-
trums of GSH and GSSG obtained from samples (n = 10) with a correspond-
ing set of data referring to the standard solution. The absence of interfering 
peaks from sample matrix and detectible amount of endogenous glutathi-
one in both forms were demonstrated with the accomplished chromato-
grams. The applied sample preparation protocol along with the optimized 
chromatographic conditions for measurements of GSH and GSSG in biolog-
ical matrix was found to be suitable for the routine analyses. 
 
 
Calibration curve, LLOD, and LLOQ 
 
Calibration curves for both compounds (GSH and GSSG) were defined for 
the range of 0.01–200 µM. The equations for the regression analysis were:  
y = 2492.7x − 175.87, R2 = 1, for GSH and y = 6648.8x + 743.4, R2 = 1, for 
GSSG (where y is the peak area and x is the concentration expressed in µM). 
The lowest limits of detection (LLOD) were calculated to be 0.18 µM 
and 0.52 µM, while the lowest limits of quantification (LLOQ) were calcu-
lated to be 0.56 µM and 1.58 µM for GSH and GSSG, respectively. 
 
 
Precision and accuracy 
 
The coefficient of variation (C.V.) for intra-day precision test was below 
2.56% for GSH and below 1.17% for GSSG. Inter-day precision test resulted 
with the coefficient of variation (C.V.) below 4.7% for GSH and below 2.5% 
for GSSG. Accuracy, calculated as a bias in the difference between expected 
concentration and measured concentration, was below 2%. Worthwhile ana-
lytical precision and accuracy of the method make this technique a conven-
ient and reliable tool for glutathione determination (Appendix A, Table I). 





We observed that stability of biological samples does not change within 4 h 
when kept at room temperature, though considering the period of 24 h stor-
age there is a difference in keeping the sample at 4 °C and at −20 °C. It was 
observed that there is no decrease of peak areas after 24 h storage at −20 °C, 
while decrease occurs after 24 h storage at 4 °C from 0.47% to 2.93% for 





Achieved recoveries were high at all tested concentration levels, with an av-
erage value of 99.19% for GSH and 99.45% for GSSG. The results confirmed 
that sample preparation procedure does not affect GSH and GSSG analysis. 
 
 
Applicability of the Modified Method 
 
Intraperitoneal administration of Cd was chosen to mimic the inhalation of 
Cd through cigarette smoking, as tobacco leaves accumulate Cd from the 
soil. It is well known that smoking increases the risk of various cancer types, 
whereas Cd (in addition to various additives present in cigarettes) was rec-
ognized as the most significant contributor. It was intriguing to measure the 
content of GSH and GSSG in such experimental scenario because Cd de-
pletes GSH through binding to its –SH group, as well as indirectly through 
interfering red-ox associated metalloenzymes when an increase of GSSG 
might be expected.  
Interpretation of the chromatographic results for the GSH and GSSG 
requires expressing them in relation to the amount of proteins present in the 
liver tissue homogenates used for the analysis upon centrifugation. That is, 
chromatographically determined GSH and GSSG originate from the certain 
amount of the injected supernatants which were obtained after the centrifu-
gation of the defined volume of the liver tissue homogenates. Approximate-
ly the same amounts of individual tissue sections were used to prepare the 
homogenates in which the proteins were measured by standard spectropho-
tometric Lowry method [18]. Therefore, the chromatographically acquired 
results were recalculated in regard to protein status.  
Glutathione status (GSSG–GSH ratio) was determined in the liver of 
the animal subjects, intact and subacutely exposed to Cd. GSH and GSSG 
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were measured following 1, 3, 10, and 21 days of the treatment (Appendix A, 
Table II). 
Since elevated GSSG–GSH ratio indicates that glutathione cycling is ac-
tively involved in OS development (alluding to oxidatively depleted GSH), 
the presented method opens up the evaluation of OS involvement, more 
precisely, glutathione cycling engagement in Cd poisoning. Our results dis-
played a time-dependent gradual depletion of GSH in Cd-group compared 
with the control group (Appendix A, Table II). Depletion of GSH may occur 
due to its ability to bind metals (toxic Cd and/or some other essential met-
als) or because of its oxidation into GSSG. Significant time-dependent grad-
ual GSSG increase was achieved in the liver of the rats subacutely i.p. ex-
posed to Cd within first 10 days, while thereafter started to decrease. Partial 
increase of GSSG could be explained by an increased production of free rad-
icals (potent oxidizing agents) through Fenton reaction in which transition 
metals [in lower oxidation state(s)] participate together with hydrogen per-
oxide. In this particular case, essential metal status was changed upon expo-
sure to Cd, because Cd competes with essential metals at active sites of an-
tioxidative metalloenzymes. Thus, antioxidative defense was reduced 
and/or diminished by Cd [inhibition of antioxidative metalloenzymes, such 
as glutathione reductase (which catalyzes the reduction of GSSG to GSH), 
superoxide dismutase (which catalyzes dismutation of superoxide anion in-
to molecular oxygen and hydrogen peroxide – the starting compound in the 
Fenton reaction) and catalase (which decomposes hydrogen peroxide to wa-





The presented method for simultaneous determination of GSH and GSSG 
provides high reproducibility, consistent chromatographic separation under 
isocratic mode, short run time, advanced symmetry, and resolution of GSH 
and GSSG peaks (allowing more precise and accurate integration). Simpli-
fied sample preparation supports high recovery of GSH and GSSG along 
with the absence of interfering peaks from biological matrix. UV detection, 
applied instead of fluorescent, allows avoiding long-lasting derivatization 
procedure which entails the GSSG overestimation. Thus, the applied sample 
preparation protocol, along with the optimized chromatographic conditions 
for measurements of GSH and GSSG in biological matrix, was found to be 
suitable for the routine analyses. 
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If we acknowledge that oxidative stress pathway is initiated, then esti-
mation of glutathione cycle involvement in certain pathophysiological sce-
nario is fundamentally important for understanding the underlying mecha-
nism(s) triggered by some diseases/poisonings (in this particular case, Cd).  
We concluded that the GSH depletion in liver of the Wistar rats sub-
acutely exposed to Cd, occurred either due to its binding to Cd or oxidation 
into GSSG by overproduced free radicals and reduced activities of the anti-
oxidative metalloenzymes. However, we underlined that increased health 
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Table I. Accuracy and precision of GSH and GSSG measurements in spiked samples of 
rat liver homogenates 
Parameters  GSH   GSSG  
Accuracy       
Spiked concentration  
(µM) 
25 50 100 25 50 100 
Measured concentration 
 (µM) 
25.45 ± 0.65 50.44 ± 0.47 99.58 ± 1.23 25.14 ± 0.29 49.32 ± 0.22 98.18 ± 0.37 
Bias (%) 1.8 0.88 −0.42 0.56 −1.36 −1.82 
Precision       
Intra-day C.V. (%) 2.56 0.94 1.24 1.17 0.45 0.38 
Inter-day C.V. (%) 4.7 1.4 1.8 2.5 1.2 0.99 
 
 
Measurements were done in triplicate. Liver homogenates of Wistar rats 
were spiked with 25, 50, and 100 ∝M of GSH and GSSG in final concentrations. 
Precision was expressed as relative standard deviation (%), i.e., coefficient of 
variation (C.V.). Intra-day precision: five times repeated measurements of each 
sample in a single day. Inter-day precision: each sample was measured over 
five consecutive days. Values were expressed as means ± standard deviation. 
For chromatographic conditions, see Materials and Methods section. 
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Table II. Concentration of glutathione in liver homogenates of Wistar rats exposed sub-
acutely i.p. to cadmium 
Calculations  
GSH  
(nmol mg−1 prot) 
GSSG  
(nmol mg−1 prot) 
GSSG–GSH 
Group Control 0 day 32.76 ± 3.41 1.83 ± 0.09 0.056 
 Cd 1 day 25.57 ± 2.57¥ ** 2.12 ± 0.13 0.083 
  3 days 23.49 ± 2.42¥*** 
3.7 ± 0.32¥***; 
                        £*** 
0.158 
  10 days 22.21 ± 3.99¥*** 
4.7 ± 0.38¥***; 
                        £***; 
                        ╪*** 
0.212 
  21 days 
18.27 ± 2.01¥***; 
                             £**; 








Untreated group of Wistar rats (control group n = 6) and the group i.p. exposed to  
1 mg CdCl2 kg−1 day−1 for 1, 3, 10, and 21 days (Cd group: n = 24). Liver homogenates 
were used as samples. For the chromatographic conditions, see section Materials and 
Methods. The values are expressed as means ± standard deviation. Contents of GSH and 
GSSG were expressed in regard to protein status in nmol mg−1 proteins. Tukey’s test was 
used for multiple comparisons between the groups, and certain comparisons were as-
signed as follows: control and Cd — subgroups (¥); Cd1 compared to Cd3, Cd10, and 
Cd21 (£); Cd3 compared to Cd10 and Cd21 (╪); and Cd10 compared to Cd21 (µ). Level of 
significance is labeled as follows: *(p < 0.05), **(p < 0.005), and ***(p < 0.0001). 






Fig. 1a. Mixed standard solution of GSH and GSSG (100 µM). The chromatogram of  
100 µM mixed standard solution of reduced glutathione (GSH) and oxidized glutathione 
(GSSG). Chromatographic conditions: see Materials and Methods. Measurements were 
repeated 6 times from the same vial (n = 6). Repeatability of retention times and 
integrated areas of GSH and GSSG peak was presented in percentage (%) as a relative 
standard deviation (RSD) GSH: 2.85 min (RSD 0.19%, n = 6) and GSSG: 6.37 min  
(RSD 0.43%, n = 6). The obtained values for tailing factors (10%) were 1.22 and 1.13, 









Fig. 1 b.  GSH and GSSG in the liver of intact Wistar rats. 
The chromatogram of the GSH and GSSG from the liver tissue homogenate of Wistar 
rats: control group; GSH (64.6 µM): 2.85 min, and GSSG (2.89 µM): 6.17 min; 
Chromatographic conditions: see Material and Methods. The GSH and GSSG values 
(expressed in µM) ought to be recalculated per mg of proteins and finally expressed as 
nmol (GSH and/or GSSG)/mg of proteins for the appropriate discussion of the obtained 
results 







Fig. 1 c.  GSH and GSSG in the liver of experimental group of Wistar rats. 
The chromatogram of the GSH and GSSG from the liver tissue homogenate of Wistar 
rats: the experimental group treated with Cd: GSH (26.24 µM): 2.70 min, and GSSG  
(1.24 µM): 6.07 min. Chromatographic conditions: see Material and Methods. The GSH and 
GSSG values (expressed in µM) ought to be recalculated per mg of proteins and finally 
expressed as nmol (GSH and/or GSSG)/mg of proteins for the appropriate discussion of 
the obtained results 
 
